drugset / Trial / NCT03436914

Treatment Response of Maintenance Dose of Proton Pump Inhibitor in Patients With Nonerosive Gatroesophageal Reflux Disease

NCT03436914 ↗

Completed 62 enrolled Yonsei University
NaSingle-groupOpen-labelTreatment

Summary

For ERD(erosive reflux disease), which pathogenesis is mainly the acid reflux mechanism, primary treatment is therefore PPI. However, NERD(non-erosive reflux disease) is much more complex than ERD and there are more factors causing the typical symptoms. As a result, there is no consensus for the treatment of NERD besides using PPI similar to GERD(gastroesophageal reflux diseas). This study intent to evaluate the effect of PPI(Esomezol) on NERD patients and analyze the improvement of symptoms and the factors related to the result.

Timeline

Start
2018-09-01
Primary completion
2019-10-18
Completion
2019-10-18

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomezol Unknown — —